Evidence map›Paper›PMID 32710472›Full record

ArticleJournal of cellular and molecular medicine2020

Lin28a up-regulation is associated with the formation of restenosis via promoting proliferation and migration of vascular smooth muscle cells.

Zhiwei Zou, Xiaojun Zhou, Ruzhen Zhang, Qian Zhang, Shan Jiang, Chunmei Xu, Rui Zhang, Tianyue Xie, Huangao Zhu, Piyun Gong and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. FPR2 Agonism Attenuates Restenosis by Mitigating Neointimal Hyperplasia via ELOVL6.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Article
  3. Frontiers in physiology · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Zhiwei ZouDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Xiaojun ZhouDepartment of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Ruzhen ZhangDepartment of Endocrinology and Metabology, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Qian ZhangDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Shan JiangDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Chunmei XuDepartment of Endocrinology and Metabology, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Rui ZhangDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Tianyue XieDepartment of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Huangao ZhuDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Piyun GongDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Dongmei ZhangDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Huimei MaDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Lin LiaoDepartment of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Jianjun DongDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.ORCID 0000-0002-7833-6773
Shandong University · CNBinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the potential role of Lin28a in the development of restenosis after percutaneous transluminal angioplasty, double-balloon injury surgery and mono-balloon injury surgery were used to establish restenosis and atherosclerosis models, respectively, so as to better distinguish restenosis from atherosclerotic lesions. Immunohistochemical analysis revealed that significantly higher expression of Lin28a was observed in the iliac arteries of restenosis plaques than that of atherosclerosis plaques. Immunofluorescence studies showed the colocalization of Lin28a with α-smooth muscle actin in restenosis plaques, rather than in atherosclerosis plaques, which suggested that Lin28a might be related to the unique behaviour of vascular smooth muscle cells (VSMCs) in restenosis. To further confirm above hypothesis, Lin28a expression was up-regulated by transfection of Lenti-Lin28a and inhibited by Lenti-Lin28a-shRNA transfection in cultured VSMCs, and then the proliferation and migration capability of VSMCs were detected by EdU and Transwell assays, respectively. Results showed that the proliferation and migration of VSMCs were significantly increased in accordance with the up-regulation of Lin28a expression, while above behaviours of VSMCs were significantly suppressed after inhibiting the expression of Lin28a. In conclusion, the up-regulation of Lin28a exerts its modulatory effect on VSMCs' proliferation and migration, which may play a critical role in contributing to pathological formation of restenosis.

Indexed as

AngioplastyAnimalsAtherosclerosisCell MovementCell ProliferationCells, CulturedMaleMuscle, Smooth, VascularMyocytes, Smooth MusclePlaque, AtheroscleroticRatsRats, Sprague-DawleyRNA-Binding ProteinsTransfectionUp-RegulationLin28A protein, ratRNA-Binding ProteinsLin28amigrationpercutaneous transluminal angioplastyproliferationrestenosisvascular smooth muscle cells

Identifiers

PMID32710472
PMCPMC7520293
OpenAlexW3044854791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.